The Claim
Selenomethionine reduces lipid peroxidation and cell death in human cancer cell lines HT1080 and OS-RC-2 when exposed to the ferroptosis inducers RSL3 or cystine deprivation, as measured by BODIPY-C11 fluorescence and propidium iodide staining.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Selenomethionine decreases markers of oxidative damage and cell death in human cancer cells under conditions that trigger ferroptosis, such as exposure to RSL3 or lack of cystine.
See the scientific wording
Selenomethionine reduces lipid peroxidation and cell death in human cancer cell lines (HT1080, OS-RC-2) exposed to the ferroptosis inducer RSL3 or cystine deprivation, as measured by BODIPY-C11 fluorescence and propidium iodide staining, suggesting it has broad ferroptosis-inhibiting activity across multiple cellular stressors.
What the research says
1 studySelenomethionine, a form of selenium, helps protect cells from a type of cell death called ferroptosis by reducing harmful fat damage and keeping cells alive, even when they’re under stress from chemicals like RSL3.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.